PODD (OmniPod) Market Value to Book Value Ratio

OmniPod (PODD) - corporate logo

Insulet Corporation (PODD) relies on high-tech manufacturing plants in the US and China featuring uncompromising sterility. Innovative closed-loop algorithms and wearable robotics solidify its leadership. Proven couriers guarantee supply chain security. The dynamics of the market value to book value multiple clearly demonstrate the market valuation of assets, where the latest parameter is 7.33.

Market Capitalization to Net Assets: Insulet Inc. (PODD) for 07/04/2022 - 10/28/2026
Finished products of Insulet Corp

The high market valuation of Insulet Corporation (PODD) reflects investor expectations regarding the scaling of its unique wireless technologies in diabetes therapy. By analyzing the P/BV multiple trend, which compares market value to net assets, one can determine the size of the premium for the business's innovativeness; a significant upward divergence of this indicator signals a potential overpayment for the company's tangible asset base.

Direct competitors

Market Capitalization to Book Value Ratio Boston Scientific|EW (edwards.com) - Capitalization to Book Value Ratio|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value ZBH|COO - Market Value to Book Value Ratio|Market Capitalization to Net Assets Align Corp (ALGN)|GMED: Market Capitalization to Book Value Ratio|Market-to-Book Ratio TransMedics Organ Care System TMDX|ATEC: Market Capitalization to Book Value Ratio|AORT - Market Cap to Net Assets Ratio|DJO Global - Market Capitalization to Book Value Ratio|Integra LifeSciences Inc. (IART) - Market Capitalization to Book Value|ESTA (Establishment Labs) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio BBNX|Market Value to Book Value Ratio IRADIMED (IRMD)|Market Value to Book Value Ratio Embecta Corp (EMBC)|Market Capitalization to Book Value Ratio TNDM|AXGN - Market Capitalization to Book Value|Market Cap to Net Assets Ratio SI-BONE, Inc.|OFIX - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio BVS|OrthoPediatrics (KIDS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Treace Medical (TMCI)|Capitalization to Book Value Ratio Strata Medical (SRTA)|Carlsmed Inc (CARL) - Market Cap to Net Assets Ratio|Market Value to Book Value RXST (rxsight.com)|ClearPoint Neuro - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Stereotaxis Inc STXS|STIM (NeuroStar) - Market Capitalization to Book Value Ratio|SGHT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Capitalization to Book Value Ratio|NSPR: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Jin Medical International Ltd|Market Capitalization to Book Value Ratio VANI (Vivani Medical, Inc.)|Market Cap to Net Assets Ratio xtantmedical.com (XTNT)|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Market Capitalization to Book Value Ratio|MYO - Market Value to Book Value Ratio|Envoy Medical Inc. (COCH) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Market Value to Book Value|Market Capitalization to Book Value Ratio SINT (Sintx Technologies Inc)|Market-to-Book Ratio TNON|LFWD: Market Value to Book Value Ratio|Market Value to Equity Ratio autonomix.com AMIX|Market Cap to Net Assets Ratio IVF (INVO Bioscience, Inc.)|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Market Capitalization to Book Value Ratio AXNX (Axonics, Inc.)|BIOL: Market Capitalization to Book Value|Market Value to Book Value Ratio dynatronics.com (DYNT)|FNA (Paragon 28) - Market Capitalization to Net Assets|Market Value to Book Value Ratio INVO